IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Valion BIO Inc (VBIO)

CUSIP: 918942202 | NYSE | 4 institutional holders

Quarters

Q3 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/A3i, LP
with Tumim Stone Capital, LLC
132,6719.9%New 5%+ stakeSep 4, 2026No 13F filer matched
13D/A3i, LP132,6719.9%

Institutional Holders — Q3 2026

UBS Group AG9,048
0.0% of portfolio›$25.3K
SBI Securities Co., Ltd.53
0.0% of portfolio›$148
Caitong International Asset Management Co., Ltd1
0.0% of portfolio›$3
Danske Bank A/S1
0.0% of portfolio›$3
StyleTurnoverLocationFiled
UBS Group AG
9,048$25.3K0.0%CoreMediumZurich, Switzerland2026-11-10
SBI Securities Co., Ltd.
53$1480.0%GrowthLowTokyo, Mexico2026-10-22
Caitong International Asset Management Co., Ltd
1$30.0%GrowthVery HighHong Kong, South Korea2026-10-29
Danske Bank A/S
1$30.0%GrowthLowCopenhagen V, Greece2026-11-09
−334
Sep 3, 2026
No 13F filer matched
13G/A3i, LP132,671
9.9% of class · Sep 4, 2026New 5%+ stake
with Tumim Stone Capital, LLC
No 13F filer matched
13D/A3i, LP132,671
9.9% of class · Sep 3, 2026−334
No 13F filer matched